Health-care companies ticked up as traders hedged their bets on the outlook for growth in the sector.
Health-care companies ticked up as traders hedged their bets on the outlook for growth in the sector.
Novartis and partner Ionis Pharmaceuticals are testing a drug to control levels of lipoprotein(a), a fatty particle in the blood known to be one of the major precursors to heart disease.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
May 27, 2026 17:19 ET (21:19 GMT)
Health-care companies rose as traders rotated into defensive sectors due to volatility in oil and Treasury markets.
Health-care companies fell as traders continued to rotate out of a sector beset by growth and regulatory concerns.
Health-care companies rose as traders rotated into some lagging sectors.
Health-care companies rose amid deal activity and demand for sectors less sensitive to inflation rates.
Frank Holland breaks down what traders are watching ahead of the new session.
Health care is going to resume its rightful place in big-time managers' portfolios.
